Calf Muscle Tightness in Flat Foot Subjects

January 19, 2021 updated by: Sara Hassan Kamel, Cairo University

Prevalence of Calf Muscle Tightness in Asymptomatic Flat Foot Subjects

The purpose of the current work is to determine the prevalence of calf muscle tightness in asymptomatic flat foot subjects.

Study Overview

Status

Unknown

Conditions

Detailed Description

Pes planus (Flat foot) deformity is a common chronic foot and ankle condition characterized by flattening of the medial longitudinal arch (MLA), rearfoot valgus and abduction of the midfoot on the hind foot.

A flexible pes planus is caused by tibialis posterior dysfunction, ligament loosening, Achilles tendon shortening, and weakness of the intrinsic foot muscles. These deformations cause plantar flexion and adduction of the talus bone and valgus of the calcaneus bone.

Up to our knowledge:

  1. No previous studies investigated whether all flat foot is usually associated with gastrocnemius and soleus muscle tightness or it is a random association.
  2. And whether tightness of gastrocnemius and soleus is highly found in all cases of flat foot.

Consequently this study is conducted.

Study Type

Observational

Enrollment (Anticipated)

174

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects with flexible flat foot aged between 20 and 40 years old . They should have navicular drop more than 10 mm and their body mass index is between 18.5 kg/m2 to 29.9 kg/m2.

Description

Inclusion Criteria:

  1. Subjects should have flexible flat foot.
  2. Age between 20 and 40 years.
  3. Navicular drop of more than 10 mm.
  4. Body Mass Index from 18.5 kg/m2 to 29.9 kg/m2.
  5. Subjects will sign the written consent form after the aim and methods of the study are explained clearly.

Exclusion Criteria:

  1. Subjects with history of foot and ankle surgery, trauma, fracture or dislocation.
  2. Subjects with congenital deformities in the ankle and foot.
  3. Subjects with systemic or neurologic diseases that could affect lower extremity biomechanics.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tightness of the calf muscle
Time Frame: 3 months
measuring of ankle dorsi flexion range of motion with knee extension and with knee flexion in flat foot subjects with navicular drop more than 1 cm
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2021

Primary Completion (Anticipated)

April 15, 2021

Study Completion (Anticipated)

May 1, 2021

Study Registration Dates

First Submitted

January 19, 2021

First Submitted That Met QC Criteria

January 19, 2021

First Posted (Actual)

January 22, 2021

Study Record Updates

Last Update Posted (Actual)

January 22, 2021

Last Update Submitted That Met QC Criteria

January 19, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Flat Feet

3
Subscribe